menu
    • menu

    Company profile for Anlon Healthcare Ltd

    Mix Gif-PSE
    News
    Anlon Healthcare Annual Report 2024-2025

    25 Aug 2025

    // PRESS RELEASE

    Anlon Healthcare 11th Annual Report 2023-24

    28 Oct 2024

    // PRESS RELEASE

    Anlon Healthcare 10th Annual Report 2022-23

    14 Oct 2024

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    #1

    Contact Supplier

    Website

    iPHEX India

    Exhibiting

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.youtube.com/embed/xBwxpkFRk4U?si=d6HExZIm7RJqMWYD

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    Key Products KEY PRODUCTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Anlon Healthcare manufactures high-quality Pharmaceutical Bulk Drugs & Intermediates compliant with FDA, PMDA, KFDA, cGMP & WHO-GMP.

    Related CompaniesRelated Companies

    About

    Anlon Healthcare is a research-focused pharmaceutical manufacturer based in Rajkot, specializing in bulk drugs and intermediates. The company’s products comply with international standards including FDA, PMDA, KFDA, cGMP, and WHO-GMP. Supported by strong R&D capabilities, advanced manufacturing infrastructure, and experienced professionals, Anlon Healthcare delivers reliable and compliant API solutions, with a focus on innovation, speed-to-market, and customer-centric development. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Anlon Healthcare Ltdindia-flag Flag
    Country
    Country
    India
    Address
    Address
    101/102-Silver Coin Complex, Opp. Crystal Mall, Kalawad Road, Rajkot 360005, G...
    Telephone
    Telephone
    +91 2812562538/39
    Client Email
    Email
    info@anlonhealthcare.com
    Client Website
    Website
    https://www.anlon.in/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/anlon-healthcare-limited/
    youtube
    YouTube
    https://www.youtube.com/@anlongroup9465
    Twitter
    Twitter
    Contact Info
    Others

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    iPHEX India

    Exhibiting

    envelop Contact Supplier

    iPHEX India

    Contact Supplier

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2025

    read-more

      https://www.pharmacompass.com/pdf/party/content/anlon-healthcare-ltd-party-content-5943.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/anlon-healthcare-ltd-party-content-73788.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    DATA COMPILATION #PharmaFlow

    read-more
    read-more
    CEP Q1 2026 Update: CEP 2.0, EDQM’s new guidelines strengthen ecosystem; Indian firms top list of CEPs issued

    CEP Q1 2026 Update: CEP 2.0, EDQM’s new guidelines strengthen ecosystem; Indian firms top list of CEPs issued

    PharmaCompass is introducing a new regulatory update that tracks developments in Certificates of Suitability to the Monographs of the European Pharmacopoeia, referred to as CEPs. These certificates are a critical regulatory instrument in the global pharmaceutical supply chain.Also known as a Certification of Suitability (COS), CEPs are issued by the European Directorate for the Quality of Medicines and HealthCare (EDQM), with or without inspection of the manufacturing site. A CEP must be renewed every five years from its original issue date to remain valid, regardless of any revisions made during the interim period. However, a CEP does not replace Good Manufacturing Practice certification.CEPs are recognized as a trusted reference for API quality, thereby simplifying global registration strategies. Apart from Europe, the CEP system is widely used by many regulatory authorities, including those in Canada, Australia, Brazil, Singapore and South Africa. View CEPs Issued in Q1 2026 (Power BI Dashboard, Free Excel Available)CEP 2.0 enhances regulatory clarity, brings efficiency, global interoperability There are several types of CEPs, depending on the nature of the substance and evaluation. The most common type is the Chemical CEP, which confirms that a chemically synthesized API meets standards for purity and impurity control. Then there are Herbal CEPs for herbal substances and preparations.Another key category is the TSE CEP, which addresses risks associated with transmissible spongiform encephalopathies in animal-derived materials. In addition, there are Combined CEPs that may cover multiple aspects, such as chemical quality, TSE risk, and sterility. However, biological products such as vaccines and blood products fall outside the scope of the CEP framework.In 2023, the CEP system underwent a major transformation with the introduction of CEP 2.0, which marks a shift from a largely document-based system to a more structured, transparent, and digitally aligned model. This makes it easier for companies to manage compliance while improving trust among global regulators.While increasing data and compliance requirements for API manufacturers, CEP 2.0 enables better regulatory clarity, streamlined dossier integration, and stronger global acceptance. Overall, CEP 2.0 is designed to enhance regulatory clarity while making the system more efficient and globally interoperable. View CEPs Issued in Q1 2026 (Power BI Dashboard, Free Excel Available)Indian firms issued maximum CEPs; Sun Pharma and its subsidiaries, Jubilant Biosys top listIndia topped the charts for CEPs issued, both in terms of new CEPs and revisions in the first quarter (Q1) of 2026. Indian companies were issued 81 new CEPs in Q1 2026 (as against 40 in Q1 2025) and 203 revisions (as against 129 in Q1 2025). In comparison, Chinese companies were issued 42 new CEPs in Q1 2026 (against 25 in Q1 2025) and 53 revisions (against 67 in Q1 2025). Italy came a distant third, followed by Germany and Spain.India’s Sun Pharmaceuticals and its subsidiaries topped the list of companies with the maximum number of CEPs issued— while no new CEP was issued, 27 CEPs were revised in Q1 2026. At second place was Jubilant Biosys — 21 CEPs were revised in Q1 2026.In terms of products, the maximum CEPs were issued for amlodipine besylate (a calcium channel blocker used for treating hypertension), followed by sitagliptin phosphate (a type 2 diabetes medicine) and pregabalin (a drug used to treat neuropathic pain, fibromyalgia, seizures, and generalized anxiety disorder). Both amlodipine besylate and sitagliptin phosphate had not been issued new CEPs or revisions in Q1 2025. View CEPs Issued in Q1 2026 (Power BI Dashboard, Free Excel Available)EDQM introduces new guidelines to accelerate CEP assessments The EDQM charges fees for various services related to CEPs that depend on the type of request or regulatory activity involved. In general, fees apply to handling CEP applications, revisions or renewals and for offering technical advice (where applicants seek scientific or regulatory guidance).In March 2026, the EDQM introduced two new guidelines aimed at accelerating CEP assessments. The first is a reliance-based assessment pathway, which allows regulators to leverage prior approvals from trusted authorities, such as those in the EU, UK, Australia, Canada, and the WHO pre-qualification program. The second is a fast-track assessment route designed to expedite reviews in situations such as medicine shortages and to support initiatives like the EU Critical Medicines Act.Timelines have been significantly compressed under these new pathways. Initial evaluations are completed within 46 working days, compared to up to 115 days under the standard procedure. Applicants are given 30 calendar days to respond to queries, after which regulators complete the final assessment within 23 working days.Another important regulatory update relates to electronic submissions. From April 1, 2026, the EDQM will reject non-compliant CEP applications at the point of submission. All applications must include a validated electronic Common Technical Document (eCTD) dossier along with a proper validation report, submitted in line with the updated Common European Submission Portal (CESP) guidelines. Taken together, these developments signal a more rigorous yet efficient CEP ecosystem. View CEPs Issued in Q1 2026 (Power BI Dashboard, Free Excel Available)Our viewThe shift to CEP 2.0 signals a move toward greater transparency, digitalization, and global regulatory alignment. Though enhanced disclosure and stricter e-submission requirements may increase the compliance burden, especially for smaller manufacturers, the long-term gains are expected to be significant. Going forward, companies that invest in data quality and regulatory readiness stand to gain from these changes.
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 2387

    https://www.pharmacompass.com/radio-compass-blog/cep-q1-2026-update-cep-2-0-edqm-s-new-guidelines-strengthen-ecosystem-indian-firms-top-list-of-ceps-issued

    #PharmaFlow by PHARMACOMPASS
    09 Apr 2026
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Anlon Healthcare Annual Report 2024-2025
    Anlon Healthcare Annual Report 2024-2025

    25 Aug 2025

    // PRESS RELEASE

    https://www.anlon.in/uploads/catalogues/1756372974.-2025.pdf

    PRESS RELEASE
    25 Aug 2025
    Share Share
    Anlon Healthcare 11th Annual Report 2023-24
    Anlon Healthcare 11th Annual Report 2023-24

    28 Oct 2024

    // PRESS RELEASE

    https://www.anlon.in/uploads/catalogues/1730120524.anlon_annual%20report_2024.pdf

    PRESS RELEASE
    28 Oct 2024
    Share Share
    Anlon Healthcare 10th Annual Report 2022-23
    Anlon Healthcare 10th Annual Report 2022-23

    14 Oct 2024

    // PRESS RELEASE

    https://www.anlon.in/uploads/catalogues/1729511100.-23.pdf

    PRESS RELEASE
    14 Oct 2024
    Share Share

    KEY PRODUCTS

    read-more
    read-more

    TOP RANKED SUPPLIER FOR:
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view

    Inspections and registrations

    Check the inspections & registration from this company

    ABOUT THIS PAGE

    Contact Anlon Healthcare Ltd and get a quotation

    Anlon Healthcare Ltd is a supplier offers 56 products (APIs, Excipients or Intermediates).

    Find Ketoprofen bulk with WC offered by Anlon Healthcare Ltd

    Find Loxoprofen Sodium bulk with JDMF offered by Anlon Healthcare Ltd

    Find Acetylcysteine bulk offered by Anlon Healthcare Ltd

    Find Alanyl Glutamine bulk offered by Anlon Healthcare Ltd

    Find Amoxapine bulk offered by Anlon Healthcare Ltd

    Find Artemether bulk offered by Anlon Healthcare Ltd

    Find Butamirate Citrate bulk offered by Anlon Healthcare Ltd

    Find Calcium 2-Oxo-3-Phenylpropionate bulk offered by Anlon Healthcare Ltd

    Find Calcium 3-Methyl-2-Oxobutyrate bulk offered by Anlon Healthcare Ltd

    Find Calcium 3-methyl-2-Oxovalerate bulk offered by Anlon Healthcare Ltd

    Find Calcium 4-Methyl-2-Oxovalerate bulk offered by Anlon Healthcare Ltd

    Find Calcium-DL-2-Hydroxy-4(Methylthio)Butyrate bulk offered by Anlon Healthcare Ltd

    Find Clonixin Lysine bulk offered by Anlon Healthcare Ltd

    Find Desloratadine bulk offered by Anlon Healthcare Ltd

    Find Dexketoprofen Trometamol bulk offered by Anlon Healthcare Ltd

    Find Diacerein bulk offered by Anlon Healthcare Ltd

    Find Ferric Carboxymaltose bulk offered by Anlon Healthcare Ltd

    Find Glutathione bulk offered by Anlon Healthcare Ltd

    Find Glycine bulk offered by Anlon Healthcare Ltd

    Find Ibuprofen bulk offered by Anlon Healthcare Ltd

    Find Indigo Carmine bulk offered by Anlon Healthcare Ltd

    Find Isoleucine bulk offered by Anlon Healthcare Ltd

    Find Isosulfan Blue bulk offered by Anlon Healthcare Ltd

    Find Ketoprofen Lysinate bulk offered by Anlon Healthcare Ltd

    Find L Carnitine Hydrochloride bulk offered by Anlon Healthcare Ltd

    Find L-Alanine API bulk offered by Anlon Healthcare Ltd

    Find L-Arginine bulk offered by Anlon Healthcare Ltd

    Find L-Arginine Hydrochloride API bulk offered by Anlon Healthcare Ltd

    Find L-Carnitine Tartrate bulk offered by Anlon Healthcare Ltd

    Find L-Cysteine Hydrochloride bulk offered by Anlon Healthcare Ltd

    Find L-Glutamine bulk offered by Anlon Healthcare Ltd

    Find L-Leucine API bulk offered by Anlon Healthcare Ltd

    Find L-Methionine bulk offered by Anlon Healthcare Ltd

    Find L-Ornithine L-aspartate bulk offered by Anlon Healthcare Ltd

    Find L-Selenomethionine bulk offered by Anlon Healthcare Ltd

    Find L-Theanine bulk offered by Anlon Healthcare Ltd

    Find L-Threonine bulk offered by Anlon Healthcare Ltd

    Find L-Tyrosine API bulk offered by Anlon Healthcare Ltd

    Find L-VALINE bulk offered by Anlon Healthcare Ltd

    Find Levocarnitine bulk offered by Anlon Healthcare Ltd

    Find Loxapine Hydrochloride bulk offered by Anlon Healthcare Ltd

    Find Loxapine Succinate bulk offered by Anlon Healthcare Ltd

    Find Lumefantrine bulk offered by Anlon Healthcare Ltd

    Find Lysine bulk offered by Anlon Healthcare Ltd

    Find Oxolamine Citrate bulk offered by Anlon Healthcare Ltd

    Find Oxolamine Phosphate bulk offered by Anlon Healthcare Ltd

    Find Resmetirom bulk offered by Anlon Healthcare Ltd

    Find Rifaximin bulk offered by Anlon Healthcare Ltd

    Find Rivaroxaban bulk offered by Anlon Healthcare Ltd

    Find Rupatadine Fumarate bulk offered by Anlon Healthcare Ltd

    Find Serine bulk offered by Anlon Healthcare Ltd

    Find Silodosin bulk offered by Anlon Healthcare Ltd

    Find Taurine bulk offered by Anlon Healthcare Ltd

    Find Ticagrelor bulk offered by Anlon Healthcare Ltd

    Find Tofacitinib Citrate bulk offered by Anlon Healthcare Ltd

    Find Tryptophan bulk offered by Anlon Healthcare Ltd

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search